Paradigm Strategies in Wealth Management LLC Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Paradigm Strategies in Wealth Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 871 shares of the healthcare conglomerate’s stock after buying an additional 169 shares during the quarter. Paradigm Strategies in Wealth Management LLC’s holdings in UnitedHealth Group were worth $509,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Capital Advisors Ltd. LLC grew its stake in shares of UnitedHealth Group by 1.2% in the third quarter. Capital Advisors Ltd. LLC now owns 1,839 shares of the healthcare conglomerate’s stock worth $1,075,000 after acquiring an additional 21 shares during the period. Goldstein Advisors LLC boosted its stake in shares of UnitedHealth Group by 4.6% in the 3rd quarter. Goldstein Advisors LLC now owns 1,353 shares of the healthcare conglomerate’s stock worth $791,000 after buying an additional 60 shares during the last quarter. Frank Rimerman Advisors LLC increased its position in UnitedHealth Group by 9.2% during the third quarter. Frank Rimerman Advisors LLC now owns 16,104 shares of the healthcare conglomerate’s stock valued at $9,416,000 after acquiring an additional 1,355 shares during the last quarter. Smith Salley Wealth Management boosted its position in UnitedHealth Group by 32.4% in the third quarter. Smith Salley Wealth Management now owns 3,643 shares of the healthcare conglomerate’s stock worth $2,130,000 after purchasing an additional 892 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale increased its position in shares of UnitedHealth Group by 0.6% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 936,422 shares of the healthcare conglomerate’s stock valued at $543,770,000 after purchasing an additional 5,228 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 0.7 %

Shares of UNH stock opened at $564.56 on Friday. The company has a market cap of $521.33 billion, a PE ratio of 36.78, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The stock’s 50 day simple moving average is $583.52 and its two-hundred day simple moving average is $537.96. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the business posted $6.56 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Argus upped their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Stephens decreased their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, KeyCorp began coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.